abstract |
The present invention is useful in treating diseases or disorders associated with peripheral serotonin, including, for example, gastrointestinal, cardiovascular, lung, inflammatory, metabolic, and low bone mass diseases, and serotonin syndrome and cancer Tryptophan hydroxylase (TPH), specifically spirocyclic compounds that are inhibitors of isoform 1 (TPH1). |